MEI Pharma, Inc. (MEIP) reported Q2 EPS of $0.08, $0.22 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $32.74 million versus the consensus estimate of $5.29 million.
MEI Pharma, Inc. (MEIP) reported Q2 EPS of $0.08, $0.22 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $32.74 million versus the consensus estimate of $5.29 million.